Survival benefit in patients with peripheral T‐cell lymphomas after treatments with novel therapies and clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival benefit in patients with peripheral T‐cell lymphomas after treatments with novel therapies and clinical trials

Published:2019-12-29 Issue:1 Volume:38 Page:51-58
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Ma Helen¹^ORCID,Cheng Bin²,Falchi Lorenzo¹,Marchi Enrica³,Sawas Ahmed³,Bhagat Govind⁴,O'Connor Owen A.³

Affiliation:

1. Division of Hematology and Oncology, New York Presbyterian HospitalColumbia University Irving Medical Center New York New York

2. Department of BiostatisticsColumbia University Irving Medical Center New York New York

3. Center for Lymphoid MalignanciesColumbia University Irving Medical Center New York New York

4. Department of Pathology and Cell BiologyColumbia University Irving Medical Center New York New York

Funder

American Cancer Society

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2705

Reference21 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

2. International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

3. Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

4. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

5. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral T-cell lymphoma: From biology to practice to the future;Cancer Treatment Reviews;2024-09

2. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma;Journal of Hematology & Oncology;2024-06-01

3. Influence of treatment intensity and medical comorbidities in older adults with peripheral T cell lymphoma;Leukemia & Lymphoma;2023-09-14

4. Mature T-cell and NK-cell lymphoma involvement of the central nervous system: a single center experience;Leukemia & Lymphoma;2023-08-11

5. SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target;Clinical Lymphoma Myeloma and Leukemia;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3